Skip to Content

MetLife Inc

MET: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$25.00VhvlfPyffndnpv

MetLife Has Decent Second Quarter, Lower Mortality Boosts Underwriting Results

MetLife reported a solid second quarter. Adjusted EPS excluding notable items was $1.90, which beat the FactSet consensus of $1.45. Variable investment income, which consists largely of private equity returns, was $389 million. While variable investment was down from the $1.4 billion quarterly average seen in the preceding four quarters, we believe this quarter’s result was still larger than consensus expectations. As variable investment income is reported on a one-quarter lag, we expect further declines as the second quarter of 2022 was a tough quarter for public and private markets. We will maintain our fair value estimate of $56 on the no-moat firm. We are adjusting the Morningstar Uncertainty Rating to Medium from High as we believe that more accurately reflects the risk in MetLife’s shares.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of MET so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center